Real-time enrollment status for this lupus nephritis clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05288855 |
| Recruiting Status | Terminated |
| Condition | Lupus Nephritis |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Aurinia Pharmaceuticals Inc. |
| Last Updated on CT.gov | February 10, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT05288855 is currently terminated participants. This clinical trial study for lupus nephritis is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Aurinia Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05288855 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05288855 was last updated 2 weeks ago (February 10, 2026). HelloStudys verifies this status automatically.